Global Oligonucleotide Synthesis Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

Description

List of Tables

The global demand for Oligonucleotide Synthesis Market is presumed to reach the market size of nearly USD 12.91 Billion by 2032 from USD 3.92 Billion in 2023 with a CAGR of 14.16% under the study period 2024-2032.

Oligonucleotide Synthesis refers to the chemical synthesis of nucleic acid fragments with defined chemical structures or sequences in various sizes. This process is capable of producing genes which are not existent in nature. The synthesis of oligonucleotide in the laboratory has become a reality due to the advancement in gene technology. Oligonucleotides are sought after in various biological sectors like biochemistry, molecular diagnostics, genomics, and other molecular biology applications. The advent of this synthesis technique has largely helped in advancements related to the treatment of cancer, hepatitis, and autoimmune antibodies. Improvement in molecular biology has set great expectancies related to cancer vaccine development, immunotherapy, and early detection. As automation capabilities continue to rise efficient manipulation of a living organism's genome will continue to improve.

MARKET DYNAMICS

There is a significant growth in this market due to increased research activities in the pharmaceuticals and biotechnology sectors. The rising demand for innovative diagnostic and therapeutic techniques and increased government spending for the development of genomic technologies also can fuel market growth. The market scope can be narrowed down due to a lack of resources, limited requirements and cost constraints. The lack of skilled personnel to carry out research in this newly emerging area can hinder the growth of this market. The report covers Porter's Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Oligonucleotide Synthesis. The growth and trends of Oligonucleotide Synthesis industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Oligonucleotide Synthesis market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Product & Service

Oligonucleotides
Equipment/Synthesizer
Reagents
Services

By Application

PCR Primers
PCR Assays & Panels
Sequencing
DNA Microarrays
Fluorescence In Situ Hybridization (FISH)
Antisense Oligonucleotides
Other Applications

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Oligonucleotide Synthesis market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Oligonucleotide Synthesis market include Thermo Fisher Scientific Inc., Merck KGaA, Danaher Corporation, Dharmacon Inc., Agilent Technologies, Bio-Synthesis, Kaneka Eurogentec S.A, LGC Biosearch Technologies, Biolegio, Twist Bioscience. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

Product Code: VMR11211903

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. OLIGONUCLEOTIDE SYNTHESIS - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Product & Service
- 3.7.2 Market Attractiveness Analysis By Application
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY PRODUCT & SERVICE

5.1. Overview By Product & Service
5.2. Historical and Forecast Data
5.3. Analysis By Product & Service
5.4. Oligonucleotides Historic and Forecast Sales By Regions
5.5. Equipment/Synthesizer Historic and Forecast Sales By Regions
5.6. Reagents Historic and Forecast Sales By Regions
5.7. Services Historic and Forecast Sales By Regions

6. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY APPLICATION

6.1. Overview By Application
6.2. Historical and Forecast Data
6.3. Analysis By Application
6.4. PCR Primers Historic and Forecast Sales By Regions
6.5. PCR Assays & Panels Historic and Forecast Sales By Regions
6.6. Sequencing Historic and Forecast Sales By Regions
6.7. DNA Microarrays Historic and Forecast Sales By Regions
6.8. Fluorescence In Situ Hybridization (FISH) Historic and Forecast Sales By Regions
6.9. Antisense Oligonucleotides Historic and Forecast Sales By Regions
6.10. Other Applications Historic and Forecast Sales By Regions

7. GLOBAL OLIGONUCLEOTIDE SYNTHESIS MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE OLIGONUCLEOTIDE SYNTHESIS COMPANIES

8.1. Oligonucleotide Synthesis Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF OLIGONUCLEOTIDE SYNTHESIS INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Thermo Fisher Scientific Inc.
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Merck KGaA
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. Danaher Corporation
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Dharmacon Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Agilent Technologies
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. Bio-Synthesis
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. Kaneka Eurogentec S.A
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. LGC Biosearch Technologies
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Biolegio
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Twist Bioscience
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies